Andrew Guggenhime | President and Chief Financial Officer |
Grant Pickering | Chief Executive Officer |
Jim Wassil | Executive Vice President and Chief Operating Officer |
Jeff Fairman | Vice President, Research |
Jason Gerberry | Bank of America |
Roger Song | Jefferies |
David Risinger | SVB |
Seamus Fernandez | Guggenheim. |
Jonathan Miller | Evercore |
Louise Chen | Cantor |
Joseph Stringer | Needham |
Good afternoon. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Vaxcyte Fourth Quarter and Full Year 2022 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.